Teladoc (TDOC) Receives a Hold from SunTrust Robinson

By Austin Angelo

In a report released today, Sandy Draper from SunTrust Robinson reiterated a Hold rating on Teladoc (TDOCResearch Report), with a price target of $80.00. The company’s shares closed last Monday at $83.74, close to its 52-week high of $86.30.

According to TipRanks.com, Draper is a 5-star analyst with an average return of 17.5% and a 71.6% success rate. Draper covers the Technology sector, focusing on stocks such as Computer Programs and Systems, Health Catalyst, and Veeva Systems.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Teladoc with a $85.08 average price target, which is a -0.5% downside from current levels. In a report issued on November 25, Stifel Nicolaus also initiated coverage with a Hold rating on the stock with a $83.00 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $86.30 and a one-year low of $42.08. Currently, Teladoc has an average volume of 1.32M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002 by George Byron Brooks and is headquartered in Purchase, NY.